Clearance Summary
Pirouette 014 received FDA 510(k) clearance under submission number K162316, sponsored by Arravasc, Ltd.. The device was reviewed via the Special premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 2016-11-22.
- Submission: K162316
- Applicant / Sponsor: Arravasc, Ltd.
- Clearance pathway: Special
- Review panel: Cardiovascular
- Device class: Class II
- Regulation citation: 21 CFR 870.1250
- Decision date: 2016-11-22
Classification & Regulation
This clearance is catalogued under FDA product code LIT and 21 CFR 870.1250, within the Cardiovascular review panel as a Class II device.